ReviewMacromolecular bioscience2026
Nanofibrous Platforms for Advanced Wound Therapeutics: Mechanisms, Materials, and Clinical Horizons.
Review in Macromolecular bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Polysaccharide based biomaterials for advanced wound healing applications.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Nanofibrous dressings have emerged as a transformative solution for acute and chronic wound management. This review evaluates recent advancements in wound therapeutics utilizing nanofiber platforms incorporating various bioactive agents. A comprehensive overview of the wound healing process across distinct physiological phases is provided, alongside a discussion of nanofiber fabrication methodologies and their underlying mechanisms. Particular emphasis is placed on the constituent materials and their inherent biofunctionality, specifically regarding how cellular interactions with these substrates enhance wound healing outcomes. Furthermore, we examine the clinical utility of these scaffolds in achieving hemostasis, modulating inflammation, preventing infection, and promoting angiogenesis. The review concludes by highlighting the cost-effectiveness and tunable architecture of nanofibers, underscoring their potential as the next generation of efficacious wound care systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.